Catalent (CTLT) Announces $500M Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Catalent, Inc. Announces Public Offering of Common Stock
February 3, 2020 4:12 PM ESTSOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (Catalent) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it has launched an underwritten public offering (the Offering) of $500 million of its common stock. In connection with the Offering, Catalent intends to grant the underwriters an option for 30 days to purchase up to $75 million of additional shares of its common stock.
Catalent intends to use approximately $330 million of the net proceeds from the Offering to fund the... More
